Updates are available Erratum dated 2016-09-14
Click to view Erratum: https://doi.org/10.1038/srep33011
-
Authors
Kleensang, Andre
Vantangoli, Marguerite M.
Odwin-DaCosta, Shelly
Andersen, Melvin E.
Boekelheide, Kim
Bouhifd, Mounir
Fornace, Albert J. Jr
Li, Heng-Hong
Livi, Carolina B.
Madnick, Samantha
Maertens, Alexandra
Rosenberg, Michael
Yager, James D.
Zhao, Liang
Hartung, Thomas
- License Information
-
More Information
Article History
Received: 1 March 2016
Accepted: 13 June 2016
First Online: 26 July 2016
Change Date: 14 September 2016
Change Type: Update
Change Details: A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has been fixed in the paper.
Competing interests
: Kim Boekelheide is an occasional expert consultant for chemical and pharmaceutical companies, and owns stock in Semma Therapeutics, a biotechnology company developing a cell-based therapy for diabetes. Carolina Livi and Michael Rosenberg are employees of Agilent Technologies, Inc., which is a company that manufactures and sells products used in this study.
